Listed

DiaMedica Therapeutics Inc.

DMACNasdaqCIK 1401040HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$10.5m, Q2 FY2026
Net income−$10.1m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$m3.3Research and development, Q3 FY2023, three months to 2023-09-30$3.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure3.7Research and development, Q4 FY2023, three months to 2023-12-31$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-17, accession 0001437749-25-008018. Derived: 12-month figure less the 9-month figure.Report this figure3.7Research and development, Q1 FY2024, three months to 2024-03-31$3.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure3.9Research and development, Q2 FY2024, three months to 2024-06-30$3.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-12, accession 0001437749-25-026207.Report this figure5.0Research and development, Q3 FY2024, three months to 2024-09-30$5.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure6.5Research and development, Q4 FY2024, three months to 2024-12-31$6.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure5.7Research and development, Q1 FY2025, three months to 2025-03-31$5.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure5.8Research and development, Q2 FY2025, three months to 2025-06-30$5.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure6.4Research and development, Q3 FY2025, three months to 2025-09-30$6.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure6.7Research and development, Q4 FY2025, three months to 2025-12-31$6.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure8.0Research and development, Q1 FY2026, three months to 2026-03-31$8.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure8.2Research and development, Q2 FY2026, three months to 2026-06-30$8.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure
Operating income$m(5.2)Operating income, Q3 FY2023, three months to 2023-09-30−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure(5.8)Operating income, Q4 FY2023, three months to 2023-12-31−$5.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-17, accession 0001437749-25-008018. Derived: 12-month figure less the 9-month figure.Report this figure(5.7)Operating income, Q1 FY2024, three months to 2024-03-31−$5.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure(5.6)Operating income, Q2 FY2024, three months to 2024-06-30−$5.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-12, accession 0001437749-25-026207.Report this figure(6.9)Operating income, Q3 FY2024, three months to 2024-09-30−$6.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure(8.4)Operating income, Q4 FY2024, three months to 2024-12-31−$8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure(8.1)Operating income, Q1 FY2025, three months to 2025-03-31−$8.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure(8.0)Operating income, Q2 FY2025, three months to 2025-06-30−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure(9.0)Operating income, Q3 FY2025, three months to 2025-09-30−$9.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure(9.2)Operating income, Q4 FY2025, three months to 2025-12-31−$9.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure(10.5)Operating income, Q1 FY2026, three months to 2026-03-31−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure(10.5)Operating income, Q2 FY2026, three months to 2026-06-30−$10.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure
Income tax$m0.0Income tax, Q3 FY2023, three months to 2023-09-30$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure0.0Income tax, Q4 FY2023, three months to 2023-12-31$22.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-17, accession 0001437749-25-008018. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2024, three months to 2024-03-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure0.0Income tax, Q2 FY2024, three months to 2024-06-30$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001437749-25-026207.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure0.0Income tax, Q4 FY2024, three months to 2024-12-31$9.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure0.0Income tax, Q4 FY2025, three months to 2025-12-31$10.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$7.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure
Net income$m(4.5)Net income, Q3 FY2023, three months to 2023-09-30−$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure(5.2)Net income, Q4 FY2023, three months to 2023-12-31−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-17, accession 0001437749-25-008018. Derived: 12-month figure less the 9-month figure.Report this figure(5.2)Net income, Q1 FY2024, three months to 2024-03-31−$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure(5.1)Net income, Q2 FY2024, three months to 2024-06-30−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure(6.3)Net income, Q3 FY2024, three months to 2024-09-30−$6.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure(7.9)Net income, Q4 FY2024, three months to 2024-12-31−$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure(7.7)Net income, Q1 FY2025, three months to 2025-03-31−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure(7.7)Net income, Q2 FY2025, three months to 2025-06-30−$7.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure(8.6)Net income, Q3 FY2025, three months to 2025-09-30−$8.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure(8.7)Net income, Q4 FY2025, three months to 2025-12-31−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure(10.0)Net income, Q1 FY2026, three months to 2026-03-31−$10.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure(10.1)Net income, Q2 FY2026, three months to 2026-06-30−$10.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure
Diluted EPS$ per sharenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Basic EPS$ per share(0.12)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figurenot reported(0.14)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.14 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure(0.13)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.13 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001437749-25-026207.Report this figure(0.15)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.15 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figurenot reported(0.18)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure(0.18)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure(0.17)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.17 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figurenot reported(0.19)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure(0.19)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.19 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure

Balance sheet

Cash and equivalents$5.1m, Q2 FY2026
Shareholders' equity$38.3m, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m2.2Cash and equivalents, Q3 FY2023, at 2023-09-30$2.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001437749-23-031671.Report this figure4.5Cash and equivalents, FY2023, at 2023-12-31$4.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-17, accession 0001437749-25-008018.Report this figure2.1Cash and equivalents, Q1 FY2024, at 2024-03-31$2.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-08, accession 0001437749-24-015381.Report this figure14.1Cash and equivalents, Q2 FY2024, at 2024-06-30$14.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-07, accession 0001437749-24-025198.Report this figure4.1Cash and equivalents, Q3 FY2024, at 2024-09-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure3.0Cash and equivalents, FY2024, at 2024-12-31$3.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-30, accession 0001437749-26-010342.Report this figure2.6Cash and equivalents, Q1 FY2025, at 2025-03-31$2.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure4.1Cash and equivalents, Q2 FY2025, at 2025-06-30$4.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001437749-25-026207.Report this figure3.3Cash and equivalents, Q3 FY2025, at 2025-09-30$3.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure15.6Cash and equivalents, FY2025, at 2025-12-31$15.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure4.9Cash and equivalents, Q1 FY2026, at 2026-03-31$4.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure5.1Cash and equivalents, Q2 FY2026, at 2026-06-30$5.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure
Current assets$m47.9Current assets, Q3 FY2023, at 2023-09-30$47.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001437749-23-031671.Report this figure53.7Current assets, FY2023, at 2023-12-31$53.7m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-17, accession 0001437749-25-008018.Report this figure47.5Current assets, Q1 FY2024, at 2024-03-31$47.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-08, accession 0001437749-24-015381.Report this figure55.0Current assets, Q2 FY2024, at 2024-06-30$55.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-07, accession 0001437749-24-025198.Report this figure50.8Current assets, Q3 FY2024, at 2024-09-30$50.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure44.6Current assets, FY2024, at 2024-12-31$44.6m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-30, accession 0001437749-26-010342.Report this figure37.4Current assets, Q1 FY2025, at 2025-03-31$37.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure31.1Current assets, Q2 FY2025, at 2025-06-30$31.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001437749-25-026207.Report this figure56.2Current assets, Q3 FY2025, at 2025-09-30$56.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure60.6Current assets, FY2025, at 2025-12-31$60.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure52.4Current assets, Q1 FY2026, at 2026-03-31$52.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure44.3Current assets, Q2 FY2026, at 2026-06-30$44.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure
Total assets$m58.1Total assets, Q3 FY2023, at 2023-09-30$58.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001437749-23-031671.Report this figure54.2Total assets, FY2023, at 2023-12-31$54.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-17, accession 0001437749-25-008018.Report this figure49.3Total assets, Q1 FY2024, at 2024-03-31$49.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-08, accession 0001437749-24-015381.Report this figure56.8Total assets, Q2 FY2024, at 2024-06-30$56.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-07, accession 0001437749-24-025198.Report this figure52.5Total assets, Q3 FY2024, at 2024-09-30$52.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure46.3Total assets, FY2024, at 2024-12-31$46.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-30, accession 0001437749-26-010342.Report this figure38.8Total assets, Q1 FY2025, at 2025-03-31$38.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure31.5Total assets, Q2 FY2025, at 2025-06-30$31.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001437749-25-026207.Report this figure57.0Total assets, Q3 FY2025, at 2025-09-30$57.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure61.4Total assets, FY2025, at 2025-12-31$61.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure53.1Total assets, Q1 FY2026, at 2026-03-31$53.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure45.0Total assets, Q2 FY2026, at 2026-06-30$45.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure
Current liabilities$m2.2Current liabilities, Q3 FY2023, at 2023-09-30$2.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001437749-23-031671.Report this figure2.8Current liabilities, FY2023, at 2023-12-31$2.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-17, accession 0001437749-25-008018.Report this figure2.6Current liabilities, Q1 FY2024, at 2024-03-31$2.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-08, accession 0001437749-24-015381.Report this figure3.1Current liabilities, Q2 FY2024, at 2024-06-30$3.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-07, accession 0001437749-24-025198.Report this figure4.3Current liabilities, Q3 FY2024, at 2024-09-30$4.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure5.4Current liabilities, FY2024, at 2024-12-31$5.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-30, accession 0001437749-26-010342.Report this figure4.7Current liabilities, Q1 FY2025, at 2025-03-31$4.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure4.1Current liabilities, Q2 FY2025, at 2025-06-30$4.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001437749-25-026207.Report this figure5.3Current liabilities, Q3 FY2025, at 2025-09-30$5.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure5.1Current liabilities, FY2025, at 2025-12-31$5.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure5.7Current liabilities, Q1 FY2026, at 2026-03-31$5.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure6.6Current liabilities, Q2 FY2026, at 2026-06-30$6.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure
Shareholders' equity$m55.6Shareholders' equity, Q3 FY2023, at 2023-09-30$55.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-13, accession 0001437749-24-034925.Report this figure51.1Shareholders' equity, FY2023, at 2023-12-31$51.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-30, accession 0001437749-26-010342.Report this figure46.3Shareholders' equity, Q1 FY2024, at 2024-03-31$46.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure53.4Shareholders' equity, Q2 FY2024, at 2024-06-30$53.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure48.0Shareholders' equity, Q3 FY2024, at 2024-09-30$48.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure40.7Shareholders' equity, FY2024, at 2024-12-31$40.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure34.0Shareholders' equity, Q1 FY2025, at 2025-03-31$34.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure27.2Shareholders' equity, Q2 FY2025, at 2025-06-30$27.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure51.6Shareholders' equity, Q3 FY2025, at 2025-09-30$51.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-12, accession 0001437749-25-034469.Report this figure56.1Shareholders' equity, FY2025, at 2025-12-31$56.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure47.2Shareholders' equity, Q1 FY2026, at 2026-03-31$47.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure38.3Shareholders' equity, Q2 FY2026, at 2026-06-30$38.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-10, accession 0001437749-26-026792.Report this figure

Cash flow

Operating cash flow−$8.1m, Q2 FY2026
Capital expenditure$3.0k, Q2 FY2026
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(4,797)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-13, accession 0001437749-24-034925. Derived: 9-month figure less the 6-month figure.Report this figure(3,812)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-17, accession 0001437749-25-008018. Derived: 12-month figure less the 9-month figure.Report this figure(6,653)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure(4,519)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001437749-25-026207. Derived: 6-month figure less the 3-month figure.Report this figure(4,470)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001437749-25-034469. Derived: 9-month figure less the 6-month figure.Report this figure(6,434)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$6.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure(7,149)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$7.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure(7,598)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001437749-26-026792. Derived: 6-month figure less the 3-month figure.Report this figure(6,550)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001437749-25-034469. Derived: 9-month figure less the 6-month figure.Report this figure(7,765)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$7.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure(9,082)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$9.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure(8,114)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001437749-26-026792. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k10.0Capital expenditure, Q3 FY2023, three months to 2023-09-30$10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-13, accession 0001437749-24-034925. Derived: 9-month figure less the 6-month figure.Report this figure3.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-17, accession 0001437749-25-008018. Derived: 12-month figure less the 9-month figure.Report this figure9.0Capital expenditure, Q1 FY2024, three months to 2024-03-31$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-13, accession 0001437749-25-016488.Report this figure0.0Capital expenditure, Q2 FY2024, three months to 2024-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001437749-25-026207. Derived: 6-month figure less the 3-month figure.Report this figure9.0Capital expenditure, Q3 FY2024, three months to 2024-09-30$9.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001437749-25-034469. Derived: 9-month figure less the 6-month figure.Report this figure7.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure12.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$12.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure6.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001437749-26-026792. Derived: 6-month figure less the 3-month figure.Report this figure16.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001437749-25-034469. Derived: 9-month figure less the 6-month figure.Report this figure6.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$6.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-30, accession 0001437749-26-010342. Derived: 12-month figure less the 9-month figure.Report this figure8.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$8.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001437749-26-015220.Report this figure3.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001437749-26-026792. Derived: 6-month figure less the 3-month figure.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:38 ET. Listed shows no prices and gives no investment advice.